Nicam 4% gel

Երկիր: Միացյալ Թագավորություն

Լեզու: անգլերեն

Աղբյուրը: MHRA (Medicines & Healthcare Products Regulatory Agency)

Ակտիվ բաղադրիչ:

Nicotinamide

Հասանելի է:

Dermal Laboratories Ltd

INN (Միջազգային անվանումը):

Nicotinamide

Դոզան:

40mg/1gram

Դեղագործական ձեւ:

Cutaneous gel

Կառավարման երթուղին:

Cutaneous

Դաս:

No Controlled Drug Status

Ռեկվիզորի տեսակը:

Valid as a prescribable product

Ապրանքի ամփոփագիր:

BNF: 13060100; GTIN: 5016379297007

Տեղեկատվական թերթիկ

IN THIS LEAFLET:
1.
What Nicam Gel is and what it is
used for
2. Before you use Nicam Gel
3. How to use Nicam Gel
4. Possible side effects
5. How to store Nicam Gel
6. Further information
1. WHAT NICAM GEL IS AND
WHAT IT IS USED FOR
•
Nicam Gel is a skin treatment for
inflamed pimples and spots.
•
The medical term for this condition is
mild to moderate inflammatory acne
vulgaris. It involves inflamed pimples
(papules) and spots containing pus
(pustules), often with skin redness
(erythema) and some tenderness.
The condition occurs mainly on the
face, back and chest.
•
Nicam Gel is suitable for use by
ADULTS, CHILDREN AND THE ELDERLY.
•
The ACTIVE INGREDIENT in this product
is nicotinamide. This ingredient treats
pimples and spots by its anti-
inflammatory activity, which reduces
swelling, redness and tenderness.
•
Nicotinamide is not an antibiotic, it is
related to an essential vitamin in our
diet (Vitamin B
3
.)
2. BEFORE YOU USE NICAM GEL
DO NOT USE Nicam Gel if you are ALLERGIC
(HYPERSENSITIVE) to nicotinamide or any
of the other ingredients of Nicam Gel
listed in Section 6.
TAKE CARE when using this product:
•
Only apply it to your skin.
•
When using it on your face, keep it
away from your eyes, and avoid
getting it inside your nostrils, on your
lips or inside your mouth.
•
Depending on how sensitive your skin
tends to be, it may be a good idea
initially to test the gel on a small area,
and wait 24 hours before using it on
larger areas. This is especially
advisable if you have unusually
sensitive skin or if you are treating the
face (as generally applies when using
any new treatment for the first time).
USING OTHER MEDICINES
Nicam Gel is not known to affect, or to
be affected by, any other medicines.
PREGNANCY AND BREAST-FEEDING
There are no specific restrictions to
using Nicam during pregnancy or
breast-feeding. Vitamin B derivative
requirements, such as nicotinamide, are
increased during pregnancy and infancy.
However, although there are no known
potential risks, as with any medicine
caution

Ապրանքի հատկությունները

OBJECT 1
NICAM 4% W/W GEL
Summary of Product Characteristics Updated 07-Dec-2017 | Dermal
Laboratories Limited
1. Name of the medicinal product
NICAM™ 4% w/w GEL
2. Qualitative and quantitative composition
Nicotinamide 4% w/w.
3. Pharmaceutical form
Topical gel.
4. Clinical particulars
4.1 Therapeutic indications
For the topical treatment of mild to moderate inflammatory acne
vulgaris.
4.2 Posology and method of administration
Apply to the affected area twice daily after the skin has been
thoroughly washed with warm water and
soap. Enough gel should be used to cover the affected area.
No difference in dose or dose schedule is recommended for adults,
children or the elderly.
For topical administration only.
4.3 Contraindications
Contraindicated in persons who have shown hypersensitivity to any of
its components.
4.4 Special warnings and precautions for use
For external use only and to be kept away from the eyes and mucous
membranes, including those of the
nose and mouth. If excessive dryness, irritation or peeling occurs
reduce the dosage to one application per
day or every other day.
4.5 Interaction with other medicinal products and other forms of
interaction
None known.
4.6 Pregnancy and lactation
Vitamin B derivative requirements such as nicotinamide, are increased
during pregnancy and infancy.
Nicotinamide is excreted in breast milk. As with all medicines, care
should be exercised during the first
trimester of pregnancy.
4.7 Effects on ability to drive and use machines
None known.
4.8 Undesirable effects
The most frequently encountered adverse effect reported is dryness of
the skin. Other less frequent
adverse effects include pruritus, erythema, burning sensation and
irritation.
REPORTING OF SUSPECTED ADVERSE REACTIONS
Reporting suspected adverse reactions after authorisation of the
medicinal product is important. It allows
continued monitoring of the benefit/risk balance of the medicinal
product. Healthcare professionals are
asked to report any suspected adverse reactions via the Yellow Card
Scheme at:
www.m